Adv. Oded Har-Even is the managing partner of ZAG-S&W LLP, the firm’s U.S. offices.
From his seat at ZAG-S&W’s New York offices, Mr. Har-Even coordinates the activities of the firm’s U.S. offices in New York, Boston and Washington DC, representing Israeli clients with activity in the U.S., as well as U.S. companies doing business in Israel.
Mr. Har-Even has extensive legal and business experience in corporate and securities law, financing transactions, establishing hi-tech businesses, mergers and acquisitions, equity and debt financing in the U.S. market, as well as routine reporting to the SEC and stock exchange.
In addition to his U.S. practice, Mr. Har-Even has extensive experience with the Chinese market, advising Chinese companies with mergers and acquisitions and raising capital in the U.S., as well as assisting Israeli companies with expanding their activity and dealing with the specific challenges of the Chinese market.
Expertise providing comprehensive legal advice to corporations and individuals with respect to their business activity in the U.S.
Expertise in U.S. corporate and securities law, including complex issues such as reporting obligations, sale of shares by interested parties, compliance with NASDAQ, FINRA, SEC requirements, and representing Israeli and U.S. clients versus said authorities.
Advising companies on compliance with the Foreign Corrupt Practices Act (FCPA).
Specific expertise representing investment banks and underwriters on a wide range of financing transactions in the U.S., including initial public offerings (IPOs), follow-on offerings, ATM, PIPE and other kinds of transactions.
Extensive experience representing and advising Israeli companies acquiring U.S. companies, establishing activity and joint ventures in the U.S., as well as ongoing and comprehensive representation on various aspects of activity in the U.S.
Expertise advising companies in sectors such as life sciences, software, hardware, manufacturing and services.
Representing RADCOM raising USD 23 million in equity on NASDAQ
Representing Mazor Robotics in a strategic agreement versus global giant Medtronic. Mazor Robotics is engaged in development, manufacturing and marketing innovative medical devices, and its shares are listed on TASE and NASDAQ.
Ongoing and comprehensive representation of Israeli companies with business activity in the U.S., including Alcobra Pharma (NASDAQ: ADHD), BIOBlast Pharma Ltd. (NASDAQ: ORPN), Pluristem Therapeutics, Inc. (NASDAQ: PSTI).
Representing ClickSoftware, Inc. in the final agreement for acquisition by Francisco Partners Management L.P., a leading private technology focused investment fund, for a consideration of USD 430 million.
Handling the business activity of Osem in the U.S.
Advising the leading investment bank Aegis Capital Corp as underwriter of many investment transactions, mostly in the life sciences sector, such as Rennova Health, Rosetta Genomics, and more.
Bachelor of Laws, LL.B. cum laude from Tel Aviv University.
Master of Laws, LL.M. in Corporate Law from New York University.
Diploma in Business Administration with a specialty in financing, New York University School of Business Administration (APCLB), 2002.
New York, 2002